Ava is a leading contributor and editor at Injury Lawyer News. She covers all aspects of the pharmaceutical industry from FDA regulation and recalls to corporate issues and litigation.
An Iowa man is suing Johnson & Johnson and its subsidiary Janssen, claiming the defendants failed to adequately warn about Invokana side effects, which purportedly resulted in a partial leg amputation. According to the complaint, brought on December 13, 2017 in New Jersey Superior Court,... Read More
Earlier this month, a Philadelphia jury ordered drug makers Johnson & Johnson and Bayer to pay $28 million to an Indiana plaintiff in the state’s first Xarelto trial. Jurors concluded that the pharmaceutical giants, which developed the blood thinning medication jointly, failed to adequately warn consumers... Read More
Early hip implant failure has plagued numerous manufacturers, leading to mass litigation against companies like DePuy, Stryker Corporation, Zimmer and Wright Medical. While advancements in artificial prosthetics have promised better mobility and fewer risks of complications, emerging research suggests that newer hip replacement designs are... Read More
Pharmaceutical giant Johnson & Johnson has been hit with another courtroom loss in its ongoing talcum powder litigation. Last week, jurors in Los Angeles ordered the company to pay a record $417 million verdict to a 63-year woman who alleged that her terminal ovarian cancer... Read More
A St. Louis jury has ordered Johnson & Johnson to pay a $110 million verdict in a talcum powder trial last week. The plaintiff, 62-year-old Lois Slemp, developed ovarian cancer after using the company’s Shower-to-Shower and Baby Powder for decades, and claimed she wasn’t adequately warned... Read More
After previously denying a motion to centralize claims alleging that the Mirena IUD causes or contributes to the development of intracranial hypertension injuries, the U.S. Judicial Panel on Multidistrict Litigation has reconsidered, given the growing number of federal actions pending in courtrooms across the nation.... Read More
Hundreds of IVC filter lawsuits alleging defective design, misrepresentation in marketing, and failure to warn have been leveled against Cook Medical since 2013. The complaints center around problems with the company’s inferior vena cava filters, small cage-like devices which are designed to prevent the development... Read More
A new class of diabetes drugs known as SGLT2 inhibitors has been associated with an increased risk of ketoacidosis, according to a May 2015 safety alert from the FDA. Medications marketed under the brand names Farxiga, Xigduo XR, Invokana and Invokamet were the topic of... Read More
